,לורנס שטרנטל, שותף במחלקת הנדל”ן הבינלאומי במשרדנו בתל אביב .מייצג את כלל ביטוח במסגרת עסקת נדל”ן גדולה בארה”ב כפי שדווח ביום א’, 24 במאי, בכלכליסט, כלל ביטוח וענקית הביטוח האמריקאית מטלייף .הקימו שותפות שתתמקד בהקמת נדל”ן בארה”ב ,כבר כעת, יצאו לדרך שלושה פרויקטים במסגרת השותפות .בהם נבנים שטחי מסחר, יחידות דיור ואף מרכז הפצה גדול… Continue Reading
מה יתרונם של סטארטאפים מקומיים מול מקביליהם הזרים? אילו תעשיות צומחות בלב התקופה הנוכחית ואילו הזדמנויות חבויות בסקטורים החווים את הקשיים הרבים מכל? מדוע יתכן וחברות הזנק ישראליות שנחשבות תמיד לאנדרדוג בקונטקסט העולמי, תהיינה אטרקטיביות יותר להשקעות בתקופה הקרובה? אילו מדינות מתחילות להראות סימנים של חזרה לשגרה בבחינת השקעות ולאילו נראה שייקח זמן ממושך יותר? … Continue Reading
Congratulations to Riskified on their Series E funding round of $165 million! Greenberg Traurig is proud to have represented an institutional investor in this transaction, and excited to have been part of this incredible achievement. For more details, please click here.… Continue Reading
In a matter led by Shareholder Joey Shabot and Associate Aaron Katz, Greenberg Traurig recently represented Wells Fargo Strategic Capital – the venture capital arm of Wells Fargo & Co and a specialized capital provider that partners with the bank’s wholesale businesses to identify and provide customized capital solutions to its clients – in its investment … Continue Reading
Tel Aviv Managing Shareholder Joey Shabot and Of-Counsel Ephraim Schmeidler recently represented a US-based family office as part of its investment into Israeli company Sight Diagnostics Ltd (Sight). Sight develops a platform for diagnosing blood diseases using computer vision technology and is a portfolio company of Clal Biotechnology Industries Ltd., traded on the Tel Aviv … Continue Reading
On the eve of the new Jewish year, Maariv, one of Israel’s oldest and most respected publications, asked some leaders of the business community in Israel to share their most significant achievement from the past year. Among the eight people selected by Maariv was Gary M. Epstein, managing shareholder of Greenberg Traurig’s Tel Aviv office; … Continue Reading
On June 6, the Boston office of Greenberg Traurig hosted the Wharton Israel Conference “Spotlight on Israeli Innovation in Healthcare and Biopharmaceuticals” for Boston area biotechnology and pharmaceutical professionals with Israeli connections. Roman Fayerberg (Boston IP) gave the welcome remarks and Chinh H. Pham (Boston IP) moderated a discussion panel “From Idea to Implementation: A … Continue Reading
Known to many as the “Start-up Nation,” Israel has also been dubbed “Silicon Wadi”; ranking 7th amongst all countries in venture capital activity outside of the U.S. In 2015 alone, there were 326 VC investments in Israel, approximately 60% of which were in the information technology sector. In a recent article entitled Inside Silicon Wadi: … Continue Reading
“…So a world-class chef and a Texan real estate investor walk into an Israeli bar.” Sound like the beginning of corny joke? Not quite. In February, team members from the recently completed “Texas Retail” deal gathered to celebrate the acquisition by Migdal and Menora, two of Israel’s largest financial institutions, of a significant interest in … Continue Reading
On Jan. 25, 2,400 investors and leaders of the burgeoning start-up scene in Israel braved a rare snowy day in Jerusalem (just days after the east coast of the U.S. was itself covered in snow) to attend the OurCrowd Global Investor Summit. Greenberg Traurig was proud to be a platinum sponsor of this successful event, … Continue Reading
Despite the close US-Israel relationship, Israeli companies and funds seeking to invest in US technologies can face US national security scrutiny that could significantly delay deals, and in some cases prevent or unwind the transaction. Israeli investment in US technology companies, however, should continue to be regarded as an attractive option, as long as the … Continue Reading
